Corus Pharma
Driving advancements in respiratory health with innovative inhalable treatments.
est. 2001
mCureX Therapeutics, Inc.
Pharmaceuticals, focuses on the research and development of mRNA (messenger RNA) vaccines and therapeutics.
6 employees · est. 2021 · Korea South
Corus Pharma is the older company (2001 vs 2021).
Side-by-Side Comparison
| Metric | Corus Pharma | mCureX Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2001 older | 2021 |
| Headquarters | ||
| Headquarters | Not tracked yet | Korea South |
| Employees | ||
| Employees | Not tracked yet | 6 |
| Industry | ||
| Industry | Biotechnology, Health Care, Pharmaceutical | Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series Unknown | Not tracked yet |
| Total Funding | ||
| Total Funding | $150.20M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 5 | Not tracked yet |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biotech, Specialty Drugs, Respiratory Health, Inhalable Treatments, Cystic Fibrosis, Antibiotics, Infectious Diseases, Biopharmaceutical, Drug Development, Therapeutics, Acquisition, Gilead Sciences, Innovative Treatments, Lidocaine, Asthma | MRNA Vaccines, MRNA Therapeutics, RNAi Therapeutics, Preclinical Development, Clinical Development, Commercialization, Production Know-how, Modified Nucleotide Technology, FTO (Freedom To Operate), COVID-19 Vaccines, Infectious Diseases, Cancer Therapeutics, Respiratory Diseases, Liver Diseases, Proprietary MRNA Platform |
| Website | ||
| Website | coruspharma.com | mcurextx.com |
About Corus Pharma
Corus Pharma is a U.S.-based biotech and specialty drug company founded in 2001. The company focuses on advancing respiratory and infectious disease treatments through innovative inhalable therapies. Their product portfolio includes Corus 1020, an inhalable form of the antibiotic aztreonam for respi...
About mCureX Therapeutics, Inc.
mCureX Therapeutics, Inc. is a subsidiary of OliX Pharmaceuticals, specializing in the research and development of mRNA vaccines and therapeutics. The company has proprietary technology and expertise in preclinical and clinical development, as well as production know-how for designing mRNA molecular...
We will tell you when either one moves
BounceWatch watches Corus Pharma and mCureX Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Corus Pharma and mCureX Therapeutics, I... — by email.
Frequently Asked Questions
Compare Corus Pharma with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Corus Pharma on 12 Sep 2024, and mCureX Therapeutics, Inc. on 13 Nov 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.